BIOSENCY is a medical device company focused on developing smart healthcare solutions.
Biosency has raised $7.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2023.
Biosency's investors include Crédit Agricole, GO CAPITAL, Crédit Agricole Ille and Vilaine Expansion.
Biosency is headquartered in Rennes, France.
BIOSENCY is a medical device company focused on developing smart healthcare solutions.
Biosency is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Biosency — Funding & Investors." VCBacked, November 8, 2023, https://www.vcbacked.co/company/biosency. Accessed September 30, 2026.
VCBacked. (2023). Biosency — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/biosency
{{cite web |title=Biosency — Funding & Investors |url=https://www.vcbacked.co/company/biosency |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated